Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 181 AL 195

Redefining management of mild cognitive impairment and Alzheimer's disease through the shift from clinical to clinical-biological diagnosis: Insights from a single-center experience

Giuffrè GM, Battisti F, Tudor AM, Lenkowicz J, Avitabile A, Rosati AM, Martellacci N, Patarnello S, Torelli F, Cesario A, Marra C.

J Alzheimers Dis. 2026 Feb;109(4):1945-1954. doi: 10.1177/13872877251411461. Epub 2026 Jan 5.

Potential Neuroprotective Role of GLP-2 in Alzheimer's Disease: Clinical Observations, Mechanistic Insights, and Comparison with GLP-1

Czarnecki M, Baranowska-Bik A, Litwiniuk A, Kalisz M, Domańska A, Kurdyła A, Bik W.

Int J Mol Sci. 2026 Feb 6;27(3):1609. doi: 10.3390/ijms27031609.

Longitudinal subcortical volume changes and their correlations with multiple PET and fluid biomarkers in dominantly inherited Alzheimer's disease

Choo IH, Park H, Gordon BA, Bateman RJ; Dominantly Inherited Alzheimer Network.

J Prev Alzheimers Dis. 2026 Apr;13(4):100513. doi: 10.1016/j.tjpad.2026.100513. Epub 2026 Feb 27.

Serum Expression of miR-106b-3p and Its Diagnostic Significance in Alzheimer Disease

Hou D, Hou Z, Qu H, Sun M, Wang L.

Alzheimer Dis Assoc Disord. 2026 Jan-Mar 01;40(1):23-29. doi: 10.1097/WAD.0000000000000710. Epub 2026 Feb 17.

CD33 Isoform Splicing Dysregulation: A Molecular Determinant of Microglial Dysfunction in Alzheimer's Disease Pathology

Li XY, Zhang Y, Ran Z, Luo JX, Yu XQ, Lu MH.

Mol Neurobiol. 2026 Apr 29;63(1):593. doi: 10.1007/s12035-026-05886-w.

Sleep architecture and self-reported sleep quality are associated with Alzheimer's disease biomarkers in older adults without dementia

Liu S, Huang J, Calderon R, Spira AP, Mcphillips MV, Gooneratne N, Gill J, Li J.

J Gerontol A Biol Sci Med Sci. 2026 May 7;81(6):glag081. doi: 10.1093/gerona/glag081.

Pre-analytical guidelines for blood and CSF Biomarkers 2025: Recommendations from the NACC ADRC Biofluid Biomarker Best Practices Workgroup

Van Meter TE, Wilson EN, Elahi F, Rissman RA, Lago AL, Faber K, Gauthreaux K, Osorio R, Perkins M, Gray N, Morris J, Liu A, Stockwell H, Kukull W, Wilson R, Wingo TS, Kanaan NM, Russ K, Wilcock D, Biber SA, Bekris LM, Karikari TK.

Alzheimers Dement. 2026 May;22(5):e71252. doi: 10.1002/alz.71252.

From research to clinical practice: DNA methylation signatures as diagnostic tools for Alzheimer's disease

Shimoda N.

Epigenomics. 2026 Mar;18(3):303-310. doi: 10.1080/17501911.2026.2635932. Epub 2026 Feb 23.

The NIH toolbox emotion battery and cerebrospinal fluid biomarkers in Alzheimer's disease: findings from the multisite ARMADA study

Yu K, Gatchel JR, Ho EH, Hajjar I, Arnold SE, Marshall GA, Dodge HH.

J Gerontol B Psychol Sci Soc Sci. 2026 Jan 12;81(2):gbaf236. doi: 10.1093/geronb/gbaf236.

Diagnostic Value of Inflammatory Biomarkers in Differentiating Vascular Dementia From Alzheimer's Disease: A Systematic Review and Meta-Analysis

Ling Y, Sun J, Hu L, Zhao M, Chen J, Zheng Y.

Brain Behav. 2026 Apr;16(4):e71341. doi: 10.1002/brb3.71341.

From Cerebrospinal Fluid to Blood Draw: Plasma p-Tau217 as a Non-Invasive Biomarker for Alzheimer's Disease: A Fagan Nomogram-Based Meta-Analytic Study

Gebril NM, Elettreby AM, Younis AH, Moawad MHED, Hafez AM, Sayed GE, Abdelrahman KM, El-Kot SM.

Mol Neurobiol. 2026 May 4;63(1):606. doi: 10.1007/s12035-026-05864-2.

Multimodal biomarker AI techniques for early neurocognitive disorder diagnosis: A systematic review

Catino F, Castellana F, Zupo R, Giannoccaro V, Lampignano L, Petrosillo AM, Addabbo F, Sborgia G, Colacicco G, Santoro C, Boero G, Impedovo D, Zheng Y, Sardone R.

Artif Intell Med. 2026 Jul;177:103389. doi: 10.1016/j.artmed.2026.103389. Epub 2026 Mar 23.

Co-pathologies and biological processes beyond amyloid-beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies

Ferreira D, Chmiela T, Eriksdotter M, Jack CR Jr, Kalpouzos G, Marseglia A, Mecocci P, Nordberg A, Religa D, Westman E.

J Intern Med. 2026 Jun;299(6):694-710. doi: 10.1111/joim.70096. Epub 2026 Apr 16.

Interactions Between Blood Nutritional Biomarkers and Apolipoprotein E ε4 in the Progression of Mild Cognitive Impairment in Alzheimer's Disease

Lawal R, Kumar S, Chigevenga R, Coe S.

Nutrients. 2026 Apr 16;18(8):1263. doi: 10.3390/nu18081263.

Sex differences in the relationship of biomarker change to memory decline in early Alzheimer's disease: an observational cohort study

Sundermann EE, Banks SJ, Bondi MW, Martinez MA, Biegon A, Rotblatt LJ, Hildebrandt T.

Biol Sex Differ. 2026 Jan 16;17(1):38. doi: 10.1186/s13293-025-00820-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias